| Q34174090 | 21. Phantom pain |
| Q41450086 | A Comparative Study on the Efficacy of Oral Memantine and Placebo for Acute Postoperative Pain in Patients Undergoing Dacryocystorhinostomy (DCR) |
| Q36725234 | A brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer's disease |
| Q88948002 | A review of current theories and treatments for phantom limb pain |
| Q41432507 | A review of the management of phantom limb pain: challenges and solutions. |
| Q92219370 | A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain |
| Q35874148 | A treatment algorithm for neuropathic pain |
| Q47902795 | Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study |
| Q41057630 | Capsaicin 8% patch treatment for amputation stump and phantom limb pain: a clinical and functional MRI study |
| Q38365390 | Cellular prion protein protects from inflammatory and neuropathic pain |
| Q48696301 | Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees |
| Q37523991 | Current approaches with the glutamatergic system as targets in the treatment of neuropathic pain |
| Q36066043 | Emerging analgesics in cancer pain management |
| Q36860042 | Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways |
| Q37386521 | Memantine (Namenda) for neuropathic pain. |
| Q40002311 | Memantine for prophylaxis of chronic tension-type headache--a double-blind, randomized, crossover clinical trial |
| Q43061597 | Memantine for the treatment of general neuropathic pain: a narrative review. |
| Q37388456 | Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias. |
| Q37806320 | NMDA receptor antagonists for the treatment of neuropathic pain |
| Q57786856 | Phantom limb pain: a review of pharmacological management |
| Q34384692 | Phantom limb pain: a systematic neuroanatomical-based review of pharmacologic treatment |
| Q48287009 | Phantom pain reduction by low-frequency and low-intensity electromagnetic fields |
| Q24234328 | Pharmacologic interventions for treating phantom limb pain |
| Q34542554 | Pharmacologic interventions for treating phantom limb pain. |
| Q36620609 | Postamputation pain: epidemiology, mechanisms, and treatment |
| Q38691471 | Systematic review of management of chronic pain after surgery. |
| Q35041376 | Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain |
| Q24806229 | The NMDA antagonist memantine affects training induced motor cortex plasticity--a study using transcranial magnetic stimulation |
| Q46688213 | Tinnitus treatment with memantine |
| Q26796325 | Use of calcitonin in recalcitrant phantom limb pain complicated by heterotopic ossification |